Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0RA9 stock hub

LON/0RA9 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RA9is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RA9

In the news

Latest news · LON/0RA9

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-135.6

P25 -54.2P50 2.1P75 13.7

ROIC-48.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RA9 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

EUR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	69
Employees Change	5%
Employees Change Percent	8.06
Enterprise value	EUR 6.8B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	FR0012333284
Last refreshed	2026-05-10
Market cap	EUR 7.2B
Price	EUR 103
Price currency	EUR
Rev Per Employee	57,778.9x
Sector	Healthcare
Sic	2836
Symbol	lon/0RA9
Website	https://www.abivax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.06%
EV Earnings	-23.14x
EV/FCF	-48.23x
FCF yield	-1.95%
P/B ratio	18.17x
P/S ratio	1,810.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 4M
Gross Profit Growth	-63.22%
Gross Profit Growth Q	-55.37%
Gross Profit Growth3 Y	0.48%
Net Income	EUR -293.2M
Net Income Growth Years	0%
Pretax Margin	-7,226.56%
Profit Per Employee	EUR -4.2M
ROA	-38.95
Roa5y	-37.56
ROCE	-47.2
ROE	-135.6
Roe5y	-198.1
ROIC	-48.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	1,653.86%
Cagr3y	89.02%
Cagr5y	35.65%
EPS Growth Years	0
Revenue Growth	-63.22x
Revenue Growth Q	-55.37x
Revenue Growth Years	0x
Revenue Growth3 Y	0.48x
Revenue Growth5 Y	218.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.01
Assets	EUR 509.8M
Cash	EUR 462.7M
Current Assets	EUR 476.8M
Current Liabilities	EUR 54.5M
Debt	EUR 28M
Debt Equity	EUR 0.07
Debt FCF	EUR -0.2
Equity	EUR 397.1M
Interest Coverage	-8.64
Liabilities	EUR 112.7M
Long Term Assets	EUR 32.9M
Long Term Liabilities	EUR 58.1M
Net Cash	EUR 434.7M
Net Cash By Market Cap	EUR 6.02
Net Cash Growth	1,318.05%
Net Debt Equity	EUR -1.09
Tangible Book Value	EUR 375.3M
Tangible Book Value Per Share	EUR 4.78
WACC	3.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.75
Net Working Capital	EUR -35.6M
Quick ratio	8.58
Working Capital	EUR 425.9M
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	1,650.42%
200-day SMA	90.67
3Y total return	575.62%
50-day SMA	100.7
50-day SMA vs 200-day SMA	50over200
5Y total return	359.24%
All Time High	131.6
All Time High Change	-21.66%
All Time High Date	2026-01-12
All Time Low	4.57
All Time Low Change	2,156.02%
All Time Low Date	2025-04-07
ATR	4.46
Beta	-0.19
Ch YTD	-13.94
High	108.8
High52	131.6
High52 Date	2026-01-12
High52ch	-21.66%
Low	103.1
Low52	5.1
Low52 Date	2025-05-22
Low52ch	1,921.57%
Ma50ch	2.39%
Price vs 200-day SMA	13.71%
RSI	52.62
RSI Monthly	72.13
RSI Weekly	54.6
Sharpe ratio	1.26x
Sortino ratio	17.16
Total Return	-10.28%
Tr YTD	-13.94
Tr1m	3.62%
Tr1w	1.88%
Tr3m	6.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -214.7M
Operating margin	-5,384.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,135,279%
Net Borrowing	-51,497,931.5
Shares Insiders	0.63%
Shares Institutions	99.32%
Shares Qo Q	7.21%
Shares Yo Y	10.28%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -171.6M
Average Volume	32,747.15x
Bv Per Share	5.06
CAPEX	EUR -123,877
Ch1m	3.62
Ch1w	1.88
Ch1y	1,650.4
Ch3m	6.4
Ch3y	575.6
Ch5y	359.2
Ch6m	16.37
Change	-3.73%
Change From Open	-4.54
Close	107.1
Days Gap	0.84
Depreciation Amortization	927,314
Dollar Volume	18,558
Earnings Date	2026-05-25
EBIT	EUR -214.7M
EBITDA	EUR -213.7M
EPS	EUR -4.22
F Score	3
FCF	EUR -140.7M
FCF EV Yield	-2.07x
Financing CF	477,455,795
Fiscal Year End	December
Founded	2,013
Goodwill	15,933,018.7
Income Tax	EUR 5.1M
Investing CF	-7,147,351
Is Primary Listing	0
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Ma150	98.74
Ma150ch	4.42%
Ma20	101.4
Ma20ch	1.7%
Net CF	324,927,500
Next Earnings Date	2026-05-25
Open	108
Position In Range	0
Ppne	1,807,916.2
Price Date	2026-05-08
Ptbv Ratio	19.23
Relative Volume	0x
Revenue	3,986,744x
SBC By Revenue	774.55x
Share Based Comp	30,879,384
Tax By Revenue	127.97x
Tr6m	16.37%
Volume	180
Z Score	11.71

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RA9 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RA9 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RA9?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.3%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+10.3%

Negative means the company is buying back shares.

Technical

LON/0RA9 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.6

Neutral momentum band

Price vs 200-day MA

+13.7%

50/200-day relationship not available

Beta (5Y)

-0.19

Less volatile than the market

Sharpe ratio

1.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RA9

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RA9 stock rating?

lon/0RA9 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RA9 analysis?

The full report lives at /stocks/lon/0RA9/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RA9?

The latest report frames lon/0RA9 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RA9 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.